Systematic Review | Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia.

Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia – Cochrane Library

Summary: Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia – Cochrane Library

Commentary on Twitter

BREAKING: Our new Cochrane review: no evidence of clinically relevant cognitive benefit of antithrombotic therapy on top of usual Rx for cerebral small vessel disease but without dementia (but may ⬆️ bleed risk) @DrTerryQuinn @StrokeImperial @CochraneDCIG https://t.co/WaaydHdBqq pic.twitter.com/qpL9TooQNa

— Joseph Kwan, MD ?? (@drjkwan) July 13, 2022